Suppr超能文献

对直接血管成形术的考量:对最终接受溶栓药物治疗的急性心肌梗死患者门到用药时间的影响。

Consideration for primary angioplasty: impact on the door-to-drug time in AMI patients ultimately treated with thrombolytic agent.

作者信息

Brady W J, Esterowitz D, Syverud S A

机构信息

Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.

出版信息

Am J Emerg Med. 2001 Jan;19(1):15-8. doi: 10.1053/ajem.2001.18129.

Abstract

The objective of this study was to determine if consideration for percutaneous transluminal coronary angioplasty (PTCA) delays administration of thrombolytic therapy in acute myocardial infarction (AMI) patients. Retrospective medical record review of patients ultimately diagnosed with AMI who presented to the ED with chest pain and ST segment elevation on the electrocardiogram; these patients also received acute reperfusion therapy (PTCA or thrombolytic agent). AMI was diagnosed by abnormal elevations in the creatinine phosphokinase MB fraction. The study period covered 2 years (July 1, 1994 to June 30, 1996) in a university hospital ED with an annual volume of 60,000 patient-visits. The use of reperfusion therapies, time intervals, and times of presentation were recorded. Patients were divided into two groups based on cardiac catheterization laboratory (CATH) availability: (group I, CATH currently in operation, Monday to Friday, 7 am to 7 pm and group II, CATH currently not in-operation, all other times). Fifty-two patients with AMI met entry criteria. Patients were treated with thrombolytic therapy in 25 cases; PTCA in 27 cases. Patients received thrombolytic agents within statistically equivalent time intervals regardless of the period of presentation; time to thrombolytic therapy for group I patients was 38 +/- 16 minutes compared with 36 +/- 26 minutes for group II patients (P =. 891). A trend toward significance was noted in the use of PTCA compared with thrombolytic agent; Group I patients were more often treated with PTCA (19) compared with group II patients (11, P =.067). Patients were more rapidly treated with PTCA during CATH operation; the mean time to PTCA for group I patients was 73.5 minutes compared with PTCA for group II patients with 107.8 minutes (P =.033). The consideration for PTCA did not significantly delay the administration of thrombolytic therapy at the study site institution. PTCA was initiated more rapidly in patients presenting with AMI during hours of CATH operation.

摘要

本研究的目的是确定在急性心肌梗死(AMI)患者中,考虑进行经皮腔内冠状动脉成形术(PTCA)是否会延迟溶栓治疗的给药。对最终诊断为AMI且因胸痛和心电图ST段抬高而就诊于急诊科的患者进行回顾性病历审查;这些患者也接受了急性再灌注治疗(PTCA或溶栓剂)。通过肌酸磷酸激酶MB分数异常升高来诊断AMI。研究期涵盖了一所大学医院急诊科的2年时间(1994年7月1日至1996年6月30日),该急诊科年就诊量为60000人次。记录了再灌注治疗的使用情况、时间间隔和就诊时间。根据心导管实验室(CATH)的可用性将患者分为两组:(第一组,CATH目前在周一至周五上午7点至晚上7点运行;第二组,CATH目前不运行,其他所有时间)。52例AMI患者符合入选标准。25例患者接受了溶栓治疗;27例患者接受了PTCA。无论就诊时间如何,患者在统计学上等效的时间间隔内接受了溶栓剂治疗;第一组患者接受溶栓治疗的时间为38±16分钟,而第二组患者为36±26分钟(P = 0.891)。与溶栓剂相比,PTCA的使用存在显著趋势;第一组患者接受PTCA治疗的频率更高(19例),而第二组患者为11例(P = 0.067)。在CATH运行期间,患者接受PTCA治疗的速度更快;第一组患者接受PTCA的平均时间为73.5分钟,而第二组患者为107.8分钟(P = 0.033)。在研究地点机构,考虑进行PTCA并未显著延迟溶栓治疗的给药。在CATH运行时间内就诊的AMI患者启动PTCA的速度更快。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验